Primary thyroid lymphoma management requires a swift and coordinated strategy among various medical specialists. Although it is rare, this malignancy grows with alarming speed. Consequently, patients often experience severe tracheal compression or direct airway invasion. In a recent clinical case, a 66-year-old female presented with thyroid diffuse large B-cell lymphoma (DLBCL). Additionally, the tumor had already invaded her trachea. Therefore, clinicians prioritized a comprehensive plan to resolve the immediate airway threat while simultaneously treating the underlying cancer.

Multidisciplinary Primary Thyroid Lymphoma Management

Successful treatment usually begins with an accurate diagnosis through core biopsy and imaging. However, clinicians must act quickly because these tumors can expand rapidly. For example, some masses double in size within just a few days. For this specific patient, the surgical team performed a total thyroidectomy to reduce the tumor burden. Subsequently, the oncology team initiated the R-CHOP regimen. Specifically, this protocol includes rituximab and several potent chemotherapy agents. Furthermore, this systemic approach successfully targeted invasive cells that surgery alone could not reach.

The patient ultimately achieved complete remission of the tracheal invasion. As a result, she avoided a high-risk tracheal resection. Moreover, her quality of life improved significantly without long-term airway morbidity. Truly, this case underscores the immense value of multidisciplinary boards in managing locally advanced disease. Indeed, combining surgical debulking with modern chemo-immunotherapy provides a robust recovery path. In fact, most patients respond very well to this combined treatment modality when diagnosed early.

Thus, medical teams should always consider lymphoma when they evaluate a rapidly expanding neck mass. While anaplastic thyroid cancer appears similar, the prognosis for lymphoma is often much better with appropriate care. For instance, prompt therapy can prevent the need for permanent tracheostomies or stents. Additionally, early intervention reduces the risk of systemic spread. Overall, collaboration remains the cornerstone of modern care in these complex hematological cases.

Frequently Asked Questions

What is the standard chemotherapy for thyroid DLBCL?

The standard treatment is the R-CHOP regimen, which consists of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. Doctors often combine this with surgery or radiation depending on the clinical stage.

Can thyroid lymphoma cause sudden airway obstruction?

Yes, because the tumor grows rapidly, it frequently compresses or invades the trachea. Consequently, patients may report the sudden onset of shortness of breath, stridor, or hoarseness.

Is surgery required for all thyroid lymphoma cases?

Surgery is primarily used for diagnostic biopsy or palliative debulking to relieve pressure. However, systemic chemo-immunotherapy remains the definitive treatment for the underlying malignancy.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Hu Z et al. Multidisciplinary diagnosis and treatment of thyroid diffuse large B cell lymphoma with tracheal invasion: a case report. J Med Case Rep. 2026 Mar 07. doi: 10.1186/s13256-026-05940-0. PMID: 41795121.

Yi J et al. Management of Primary Thyroid Diffuse Large B-cell Lymphoma. Medscape Reference. 2025.

Lapadat et al. Approach to primary thyroid lymphoma: case series. PMC. 2019.